Federal contract award
36C77025P0195
NALTREXONE (EQV-REVIA) 50MG
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | NATIONAL CMOP OFFICE (36C770) |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $922.0K |
| Current contract value | $922.0K |
| Potential contract value / ceiling | $922.0K |
| Start date | Jun 9, 2025 |
| Current end date | Jun 30, 2025 |
| Potential end date | Jun 30, 2025 |
| Latest award activity | Jun 9, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 9, 2025 | 0 | $922.0K | NALTREXONE (EQV-REVIA) 50MG |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.